Close Menu

NEW YORK, Oct 3 - Structural genomics company Syrrx said Tuesday it has completed a $20 million Series B round of venture financing.

MPM Asset Management led the private placement. Nicholas Galakatos, general partner at MPM Asset Management, will be joining Syrrx's board of directors.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers tie a variant in ADAMTS3 to breathing difficulties in dissimilar dog breeds, according to Discover's D-brief blog.

The Japan Times reports that researchers sequenced the genome of a woman who lived during the Jomon period.

Parents of children with rare genetic disease have to contend with shifts in the interpretation of genetic variants, the Wall Street Journal reports.

In Science this week: single-nucleus RNA sequencing of brain tissue from individuals with autism, and more.